Stroke
Article
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
The Food and Drug Administration reaffirmed its confidence in the data supporting the claim that rivaroxaban (Xarelto) is a safe and effective...
From the Journals
Cerebral protection in TAVI reduces ischemic brain lesions
In patients undergoing transcatheter aortic valve implantation, use of a cerebral protection device to entrap and remove embolic debris reduced...
Conference Coverage
Conference News Roundup—European Society of Cardiology
Low socioeconomic status is associated with a higher risk of a second heart attack or stroke, according to Joel Ohm, MD, a physician at the...
News
Benefits of early endovascular thrombectomy outlined in five trials
Key clinical point: Endovascular thrombectomy started within 7.3 hours of symptom onset for large-vessel ischemic stroke produces better outcomes...
Conference Coverage
Ticagrelor slashes first stroke risk after MI
ROME – Ticagrelor reduced the risk of a first stroke by 25% in patients with a prior MI.
News
Clot retrieval devices approved for initial ischemic stroke treatment
Conference Coverage
Andexanet controlled factor Xa inhibitor–related bleeding
Key clinical point: Andexanet alfa achieved effective hemostasis in most patients with acute major bleeding on factor Xa inhibitors. Major finding...
Conference Coverage
CPAP fell short for preventing cardiovascular events
Key clinical point: About 3.3.
Conference Coverage
VIDEO: NOACs cut intracranial bleeds in real-world atrial fib patients
Literature Review
Intensive Blood Pressure Treatment Does Not Improve Outcomes in Acute Intracerebral Hemorrhage
When treating an acute hypertensive response in patients with intracerebral hemorrhage, intensive blood pressure treatment does not result in a...